Abstract
Cardiovascular disease (CVD) is a major threat to human health since it is the leading cause of death in western countries. Atherosclerosis is a type of CVD related to hypertension, diabetes, high levels of cholesterol, smoking, oxidative stress, and age. Atherosclerosis primarily occurs in medium and large arteries, such as coronary and the carotid artery and, in particular, at bifurcations and curvatures. Atherosclerosis is compared to an inflammatory disease where a thick, porous material comprising cholesterol fat, saturated sterols, proteins, fatty acids, calcium etc., is covered by an endothelial membrane and a fragile fibrous tissue which makes atheromatic plaque prone to rupture that could lead to the blockage of the artery due to the released plaque material. Despite the great progress achieved, the nature of the disease is not fully understood. This paper reviews the current state of modelling of all levels of atherosclerosis formation and progress and discusses further challenges in atherosclerosis modelling. The objective is to pave a way towards more precise computational tools to predict and eventually reengineer the fate of atherosclerosis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
The pathophysiology of atherosclerosis
Atherogenesis is an inflammation-related procedure associated with high concentration of low-density lipoprotein (LDL) in the blood and is affected by systemic risk factors such as hypertension, smoking, hyperlipidemia, hyperhomocysteinemia, and diabetes mellitus.23 It usually occurs in regions near bifurcations, curves and artery branches where disturbed flow patterns take place and subsequently low values of endothelial shear stress (ESS) are expected.14 Endothelial cells (ECs) tend to change their morphology when subjected to wall shear stress, i.e. their shape is either elongated under high wall shear stress or rounded/polygonal with no particular alignment pattern under low or oscillating wall shear stress.85 These conformational changes of ECs associated with low ESS might be responsible for the widening of the junctions between ECs, therefore these small “gaps” between ECs, in combination with flow stagnation and the subsequent prolongation of the residence time of circulating LDL, facilitate the infiltration of LDL underneath the endothelium.14 The LDL in the artery wall is modified by oxygen radicals to oxidized LDL (oxLDL) causing oxidative stress which in turn induces endothelial cells to express adhesion molecules serving as ligands of leukocytes receptors, such as vascular cell-adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and P-selectins27 subsequently causing the adhesion of blood-borne leukocytes (mainly monocytes and T cells). In addition, oxLDL particles stimulate ECs and smooth muscle cells (SMCs) to secrete monocyte chemotactic protein-1 (MCP-1) and monocyte colony stimulating factor (M-CSF).103 Once adherent, the leukocyte infiltrates between intact endothelial cells to penetrate into tunica intima. This directed migration requires a chemoattractant gradient: (i) for monocytes it is the particular interaction of MCP-1 that binds to its receptor CCR2 expressed by the monocyte; (ii) for T-cells known chemoattractants include a trio of interferon-γ (IFN-γ)-inducible chemokines of the CXC family that bind to chemokine receptor CXCR3 expressed by T cells.60
M-CSF induces entering monocytes to differentiate into macrophages41 that bind with oxLDL either via scavenger receptors (SR) or toll-like receptors (TLR) expressed on their surface. Binding with SRs internalizes oxLDL and leads progressively to the formation of a foam cell, so named because of the foamy appearance under the microscope, which is the result of the accumulation of lipid droplets within the cytoplasm.60 During this procedure, internalization and processing of oxLDL induce the presentation of its fragments as antigens on the cell surface and this property of macrophages deems them as antigen-presenting cells (APC). On the other hand binding with TLR can initiate a signal cascade that leads to cell activation by which the activated macrophage produces inflammatory cytokines such as tumour-necrosis factor (TNF), proteases such as matrix metalloproteinases (MMP), and oxygen and nitrogen radical molecules.40,103 HDL-associated Paraoxonase 1 (PON1) inhibits the influx of cholesterol by oxLDL into macrophages by reducing oxLDL levels, reducing oxLDL uptake via the macrophage scavenger receptor and also enhances HDL-mediated cholesterol efflux from the arterial wall into plasma and then to the liver.27
T cells in the tunica intima are in search for antigens and undergo activation after interacting with APCs, such as macrophages.41 The outcome is their differentiation predominantly into T helper 1 (TH1) cells that produce inflammatory cytokines including interferon-γ (IFN-γ) and TNF. These cytokines and others prompt macrophage activation, production of other pro-inflammatory mediators, activate endothelial cells and increase adhesion-molecule expression.27 In addition, inflammatory cells residing in the plaque, including macrophages, produce angiogenic mediators such as vascular endothelial growth factor (VEGF) promoting neovascularization (Fig. 1).60
Thereby the inflammation cycle is maintained, and the atherosclerotic plaque progressively develops. This is formed as (i) the core filled with lipids, including cholesterol crystals, living and apoptotic foam cells and (ii) the fibrous cap consisted of mainly smooth muscle cells and collagen. The mechanism of the formation of the fibrous cap starts with the activation of endothelial cells by oxidative stress and subsequent secretion of platelet-derived growth factor (PDGF) that promotes medial and pre-existing SMCs to migrate near the endothelium. Furthermore, lipid-laden macrophages also secrete PDGF inducing SMC migration through and around them69 and also basic fibroblast growth factor (FGF) that induces SMC proliferation.63 In addition, within the developing plaque, the newly developed microvascular vessels may be particularly prone to micro-haemorrhage which leads to thrombin generation triggering platelet release of PDGF, further stimulating SMC migration.60 Collagen production from SMCs is upregulated by transforming growth factor—beta (TGF-β) which is a pluripotent cytokine secreted by a number of cells, including macrophages, platelets, endothelial cells and SMCs.41 Interstitial collagen molecules confer most of the tensile strength on the fibrous cap.60 This continuous process produces a distinct fibrous cap that maintains plaque integrity and avoids contact of the thrombogenic necrotic core with flowing blood.84 As the plaque becomes more bulky it may protrude into the lumen hampering thereby blood flow consequently leading to ischemia and subsequent clinical manifestations such as angina (Fig. 2).60
Plaque vulnerability is promoted by the presence of (i) IFN-γ, which counteracts fibrous cap formation by enhancing collagen degradation and inhibiting smooth muscle cell proliferation and (ii) MMPs that degrade collagen fibers37 and are, however, counteracted by tissue inhibitors of metalloproteinase (TIMPs) synthesized by ECs, SMCs and macrophages.88 Therefore, the weakened cap, which cannot withstand the hemodynamic forces may rupture and consequently, expose thrombogenic plaque material (tissue factor) to the blood stream.41 The subsequent precipitation of platelets and coagulation factors forms a thrombus which if occludes the vessel persistently can lead to an acute myocardial infarction.60 If the thrombus detaches it may lead to occlusion of important vessels in the circulatory system including cerebral vessels thus leading to a stroke.
Mathematical Modelling of Atherosclerosis Formation
LDL Mass Transport
Haemodynamics
Blood flow can be either described by the Navier–Stokes (N-S) equation or the modified N-S incorporating Womersley parameter. In the first case Navier–Stokes and the continuity equations of incompressible fluid are:
where μ is the dynamic viscosity of blood, u is the blood velocity vector in the vessel, ρ is the blood density, and p is the pressure.
In the second case, the general form of the non-dimensional N-S with Womersley parameter is given as94:
where the square root of the oscillatory Reynolds number \(a = R\left( {\omega /v} \right)^{1/2}\) is known as Womersley parameter, ω is the circular frequency, R is the inlet radius, Re1 = max {1, Re} and K is the medium Darcian permeability. The Womersley parameter can be interpreted as an estimation of the distance from the artery wall where the viscous forces are of equal magnitude to the inertia. This type of N-S equation addresses time–periodic pressure gradient driving the Poiseuille flow.
Mass transfer of LDL in the blood vessel is coupled with the blood flow N-S equation and is modeled by the general form of the advection–diffusion equation
where c is the average solute concentration in the blood, and D is the solute diffusivity and the Eulerian approach is followed.
In the case of the modified N-S equation mass transfer in the lumen is described with an advection–diffusion equation with Womersley parameter94:
where c is the non-dimensional species concentration and Sc is the Schmidt number. An alternative non-dimensionalisation employing the Péclet number (Pe) can be used26 considering that Pe = Re·Sc. Mass in the wall is described by the following non-dimensional equation
Sceff is the effective Schmidt number given as Sceff = v/Deff, Deff is the effective diffusivity of species in the wall, Reeff is the effective Reynolds number given as Reeff = B*Re and H is a normalized first order reaction rate for species binding and degradation by the cells of the media and B is a measure of the interactions between the transported species and the wall components.94
LDL Infiltration Across the Arterial Wall
The endothelium permeability of the arterial wall is shear stress depended. Due to the blood flow, a frictional force is exerted on the arterial wall, i.e. the wall shear stress (WSS), given by the following equation:
where τw is the WSS, µ is the dynamic viscosity of the fluid, u is the fluid velocity along the boundary and r is the radial distance from the boundary (the wall). The interconnection between the endothelial transport properties and WSS is expressed by the endothelial cell shape index function (SI), where a portion of the cells will behave as leaky cells (φ) enhancing the endothelium permeability to LDL.25,99 The amount of LDL and leaky cells determine the transport conditions of the porous model in the lumen.7,18,70,100 However, in the near-wall region, the WSS also affects the local transport of atherogenic biochemicals from the fluid towards the tissue.6 In addition, the LDL mass transfer can be affected by the artery movement.54
Arterial Tissue as Porous Medium
The arterial wall can be treated as a porous medium composed of dispersed cells separated by connective voids where blood flows.51 The Darcy Law, the Darcy–Forchheimer model, the Brinkman model, the Vafai and Tien, and the Brinkman–Forchheimer–Darcy equation are amongst the transport models that have been proposed to describe the biological phenomena.50
The Darcy law represents a linear relationship between the flux and the pressure gradient across the porous medium:
where k is the permeability tensor, q is the flux, μ the dynamic viscosity, and \(\nabla p\) is the pressure gradient. The fluid velocity u is related to the flux through the porosity φ:
Darcy–Forchheimer model is a modified model to account for the inertial effects based on a permeability-based Reynolds number and is defined as:
where cF is a dimensionless parameter related to inertial effects. The permeability-based Reynolds number for the transition to the Darcy–Forchheimer model is defined as:
where up, K, and v are the pore velocity, permeability, and kinematic viscosity, respectively. Brinkman’s model takes into account porous medium solid walls and introduces no-slip boundary conditions and is given by:
where μe is the effective viscosity of the porous medium. In both Darcy and Brinkman transport models the advection–diffusion Eq. (4) can be implemented.
Vafai and Tien101 proposed a generalized volume averaged model of the expanded Brinkman equation for flow transport through porous media defined as:
where ε is the medium porosity, F and ρf are the dimensionless inertia coefficient and the fluid density, respectively. The parameters \(\left\langle P \right\rangle^{\text{f}}\) and J are the average pressure inside the fluid and a unit vector pointing along the velocity vector V, respectively. The symbol 〈 〉, represents the local volume average of a quantity associated with the fluid. In this case species transport is described by the advection–diffusion Eq. (4).
A more detailed model to address transport processes within the arterial layers was proposed by Prosi et al.74
where γ is the hindrance coefficient for the transport of species and k is the reaction rate constant.
Finally, an extensive model to describe LDL transport in each arterial layer namely the endothelium, intima, IEL and media, comprises of the following set of volume-averaged equations for the fluid flow and the species transportation was employed for the endothelium and IEL:
and for the intima and media layers
where μ′ the effective dynamic viscosity, σf is the Staverman filtration reflection coefficient, σd is the Staverman osmotic reflection coefficient, T is the absolute temperature, and Ru is the universal gas constant. It can be seen that for the IEL and endothelium the Staverman filtration and osmotic reflection coefficients, associated to the permeability of the membranes to solutes such as LDL, are incorporated in the corresponding equations.104
Arterial Tissue as Membrane
In order to resolve the cell membrane permeability characteristics, correlations for the transmural velocity (Jv) and the solute flux (Js) at the lumen–wall interface are used. These are the Kedem-Katchalsky (K–K) equations given by
where Lp is the hydraulic permeability, Δp is the pressure difference and Δπ is the osmotic pressure difference between the semipermeable membrane sides, ω is the solute permeability coefficient, σ is the reflection coefficient and \(\overline{c}\) is the mean solute concentration of endothelium.48
Another expression of the K–K equations to describe the flux across the endothelium and IEL incorporates the Staverman reflection coefficients and is given by47:
The permeability coefficient of the wall layer is P whereas Δc is the osmotic concentration difference. The Staverman osmotic reflection coefficient σd denotes the ability of as solute to induce osmotic flow in the sense that if a membrane can have pores so small as to completely exclude the solute or so large that the solute completely passes through then the full (σd = 1) or null (σd = 0) osmotic potential respectively is realized. The Staverman filtration reflection coefficient σf, denotes the ability of a membrane to sieve a solute in a filtration in the sense that σf = 1 if the solute is completely excluded and σf = 0 if the membrane is unselective.10 Albeit some studies consider σd and σf as equal3,49,104 others suggest non-equal values for σd and σf for both the endothelium and IEL.46 In addition to the latter, Shu et al87 argue that the assumption that coefficients σd and σf in the classical K–K equations are equal cannot be valid for osmosis in the nanoscale. Therefore, they propose a modified version incorporating three new parameters, namely the osmotic pressure coefficient (σo), the primary filtration coefficient (σs) and the secondary selectivity rate (x), instead of the two coefficients, that is given by
Thereby Eqs. (23) and (24) are able to accurately take into account the osmosis through nano-pores.
Traditional Kedem–Katchalsky membrane equations have two major disadvantages. First, a steady-state condition is considered in the endothelium and the IEL. Second, the boundary effects on the flow across the membrane are ignored, which is not valid when the boundaries of the porous membrane have to be accounted for.50 For this reason a modified version of Kedem–Ketchalsky’s equations for the solute flux through the endothelium has been presented:
where P is the diffusive permeability, Pe is the modified Péclet number, cw, end the LDL concentration in the arterial wall at the sub-endothelial layer, and σ is the solvent drag coefficient.73
The flux of fluid and solutes within biological membranes considering osmotic pressure and active transport mechanisms and the alteration of their ionic distribution due to their charges has been described by an enhanced K–K set of equations as:
where zk is the charge number of species k, F is the Farraday constant and Δφ is electrical potential difference, whereas summation denotes a variety of solutes.17 The enhanced K–K equations can fill the gap of the traditional version of K–K theory regarding the recovery of the Donnan equilibrium where fixed charges induce imbalance of ionic concentrations and develop an osmotic pressure gradient between the inside and outside environments of the membrane. An additional term Jai can be added at the RHS of Eq. (28) accounting for the active ionic transport. The work of Cheng and Pinsky17 is a step forward compared to previous studies of Li56 that incorporated the electrostatic potential difference between solutes, yet not able to address the Donnan equilibrium or the work of Hodson and Earlam43 using the K–K theory with fixed charges but only for binary solutions and not for active transport.
Fluid-Wall Models and Boundary Conditions
In general, numerical models of LDL mass transfer in the arterial wall have been classified into three distinct types, i.e. the wall free model, the fluid-wall single layer model and the fluid-wall multilayer model.74 The pertinent boundary conditions for fluid and solute for the different arterial transport models are described as follows.
In the wall free model, the solution of the blood flow in the lumen is independent of the mass transport mechanism within the artery wall, thus only considering the necessary boundary conditions, i.e. for instance filtration velocity value from the literature, for the wall effect. In this sense the wall-free model does not address solute concentration within the wall. For the wall-free model at the flow entrance a constant filtration velocity is prescribed and for the solute diffusive flux is used at the wall.76
The homogenous wall model is the first to address LDL transport to the arterial wall. For the homogenous wall model at the lumen inlet and outlet an “insulation” condition is used. A lumen to wall transmural velocity in the normal direction of the endothelium wall side is used. At the media-adventitia interface a pressure condition was assumed. For the solute convection–diffusion equation constant concentration and a convective flux condition were assumed at the lumen inlet and outlet. At the wall side of the endothelium a flux in the normal direction is used. Finally, a constant concentration is used at the media-adventitia interface.96
The fluid-wall multi-layer model is a very comprehensive model incorporating the wall heterogeneity considering distinctively the different properties of each arterial layer either as a membrane or as a porous medium.50 A version of this model is the four-layer model104 where the endothelium, intima, internal elastic lamina (IEL) and media are all treated as macroscopically homogeneous porous media employing Eqs. (15)–(18). The solid boundaries effects of the different porous layers are neglected. The hydraulic pressure at the lumen-endothelium and the media-adventitia interfaces are 100 mmHg. The reference filtration velocity is taken as 2.31 × 10−5 mm·s−1. Continuity of velocity is applied at the lumen-endothelium-intima-IEL-media interfaces. For the solute concentration a total mass flux boundary condition is applied at the endothelium-intima-IEL-media interfaces. At the lumen-endothelium interface net transmural flux is used. Between the media and adventitia, the boundary condition applied is \(\partial c/\partial n = 0\). In the work of Yang and Vafai105 analytical solutions for LDL transport in the arterial wall are presented but their use is limited to straight geometry.
The basic layers of the artery wall are shown in Fig. 3, whereas the pertinent mass transfer models and the corresponding boundary conditions are summarized in Tables 1 and 2 respectively.
Atherosclerosis Inflammatory Processes
LDL Oxidation and the Role of HDL
Oxidation of LDL was first modelled by Stanbro93 using an ordinary differential equation (ODE) and later on Cobbold et al.20 proposed a system of time-dependent ODEs based on in vitro experimental data. A second order kinetic reaction was used to model the interaction between LDL and free radicals. Calvez and Ebde12 proposed an improved version of this approach to describe the evolution of the oxLDL (Ox) concentration and the subsequent transformation of macrophages into foam cells. In their PDE the second term at the left-hand side represents the lesion growth indicating that the Ox molecules are transported along with the tissue deformation having velocity u. The same model was used by Silva et al.89 A similar approach was frequently used, where synthesis and turnover of oxLDL were modelled as a reaction with radicals.12,19,32,34,36,42,78,89 On the other hand, a simplified approach was proposed by Cohen et al.21 considering LDL oxidation as a constant. The works of Friedman and Hao34 and Hao and Friedman42 expanded the original model and incorporated the impact of the HDL concentration. In their analysis HDL reacts with free radicals and oxidates. Table 3 summarises the governing equations used in LDL oxidation.
MCP-1 Secretion
The response of the endothelial cells in the presence of ox-LDL is the secretion of MCP-1 that initiates the monocytes recruitment into the intima.
Hao and Friedman42 included MCP-1 production by the endothelial cells assuming a constant concentration.79 Production, diffusion and degradation rate of MCP-1 were set according to Chen et al.15 In the work of Mckay et al.64 the evolution of monocytes concentration was modeled using a differential equation considering the effect of chemo-attractants and the subsequent proliferation and the formation of macrophages. Monocytes production rate, maturing rate into macrophages, and the proliferation rate were necessary parameters for the modelling. In the model of Cilla et al.19 a diffusion-convection differential equation was used incorporating production and degradation of MCP-1. In their study diffusion and convection terms were disregarded. Cytokines production and degradation rates were set according to Siogkas et al.90 and Zhao et al.,109 and the threshold of LDL and monocytes mitosis as in Schwenke and Carew.83 In other studies, the secretion of MCP-1 was grouped together with other chemoattractants such as interleukin-1 (IL-1) and M-CSF.31,45,64,89,108 A summary of the governing equations used in the secretion of monocyte chemoattractant protein is presented in Table 4.
Monocyte Recruitment
The existence of monocytes in the lumen has rarely been considered. Cilla et al.19 presented monocyte dispersion process along the lumen and in the intima. Similar approaches for the monocyte diffusion in the wall have also been proposed.11,64 Chalmers et al.13 included monocyte chemoattractant flux into the intima. Monocyte production in the endothelial cells was determined as a function of cytokine and modified LDL concentration. The transport of monocytes through the intima-media domain has been modeled as a purely diffusion–reaction equation. In other studies a system of reaction–diffusion PDEs describing the density of immune cells (monocytes, macrophages) and the density of the cytokines secreted by the immune cells has been proposed.52,53 In other studies, the monocyte recruitment and differentiation has been simplified and incorporated into the governing equation of the macrophage density describing the conversion of macrophages into foam cells after reaction with oxLDL.12,32,89,99 Monocytes concentration in the intima could be either incorporated as a constant value32 or a function of a pro-inflammatory signal S.89 The governing equations used in monocyte recruitment are summarized in Table 5.
Monocyte to Macrophage Differentiation
Macrophage formation after taking up oxLDL is described by a reaction term.78 The evolution of oxLDL and the transformation of monocytes to macrophages were incorporated in the work of Calvez and Ebde12 and Silva et al.89 It was assumed that all monocytes would differentiate into macrophages once inside the arterial wall and the recruitment of new monocytes depends on a general pro-inflammatory signal S. Based on the hypothesis that macrophages are relatively free to travel inside the tissue, their convection is much smaller than their diffusion. Cilla et al.19 used a diffusion equation to describe the evolution of macrophages including foam cells apoptosis. The macrophages diffusion coefficient in the arterial wall was equal to the monocyte diffusion coefficient. A similar approach was followed in other studies.31,45,53 A slightly more complicated expression was proposed by Hao and Friedman42 including both chemotaxis due to MCP-1 and activation of macrophages due to IFM-γ. Tomaso et al.99 used a constant source to model monocyte penetration through the endothelium based on previous work Tedgui and Lever,98 assuming all monocytes differentiate into macrophages. Finally, Chalmers et al.13 assumed that only a proportion of macrophages convert to foam cells and a proportion (θ) of foam cells revert to macrophages due to the presence of HDL. Table 6 recaps the governing equations used in monocyte to macrophage differentiation.
Foam Cell Formation and Accumulation
Calvez and Ebde12 mathematically described foam cell production through a simple mass action law disregarding foam cell diffusion due to their relatively large size. In their work SMCs and fibers contribution to the inflammation is neglected, thus no reaction term was included in the biomass transport equation. Cilla et al.19 modeled macrophages apoptosis using a reaction term along with no-flux boundary conditions at the artery walls, and a similar approach was presented by Tomaso et al.99 Hao and Friedman42 also modeled the production and death of foam cells using a PDE. In the work of Chalmers et al.13 the inflammation procedure was modeled including cytokine production after macrophages take up ox-LDL. In addition to the foam cell formation, the non-inflammatory process was also included due to the presence of HDL and the subsequent removal of the lipid core.
A transport equation was used by Yang et al.106 for macrophages motion in the vessel wall with a reaction term representing the foam cells formation. In addition, a balance equation for the macrophage accumulation was used. A key feature of the model is that the mechanical properties of the plaque change as a result of foam cells concentration. Moreover, a linear dependence of the reaction function on the macrophages concentration and the growth function on the reaction rate was assumed.
Bulelzai and Dubbeldam11 presented their model regarding the formation of foam cells following ox-LDL uptake by macrophages. The proposed model adopts similar approaches as in previous studies.21,71 Ougrinovskaia et al.71 proposed a model neglecting small time-scale events for the lesion development without incorporating cap formation. In their work qualitative properties of the lesions instead of specific concentration of the different factors were adopted. Michaelis–Menten kinetics were used for ox-LDL uptake by macrophages. Another common point is the use of a sigmoidal function for the saturating uptake rate. Cohen et al.21 model studied the HDL effect in atherosclerosis, nevertheless, the rest of the equations were the same as in Ougrinovskaia et al.71 A synopsis of the governing equations used in foam cell formation and accumulations is tabulated in Table 7.
T Cell Recruitment and the Role of Interferon-Gamma (IFN-γ)
In most studies, the role of T-cells is rarely investigated. A very detailed approach was presented by Hao and Friedman.42 In their work, an equation for T-cells density was presented expressing T-cells activation by IL-12. The effect of IL-1 and IL-6, which are produced by macrophages and SMCs, was also taken into consideration. In addition, the IFN-γ production related to T-cells and the subsequent degradation, as well as the concentration of interleukin-12, were modeled. In their work values of all necessary parameters are tabulated. A similar approach was adopted by Friedman and Hao34 in their model for reverse cholesterol transport impact. Table 8 summarises the governing equations used in T cell and IFN-γ recruitment.
Proliferation of SMCs
Another scarcely studied factor is the role of the SMCs in atherosclerosis.
A detailed study of the role of SMCs was presented by Hao and Friedman42 considering the PDGF secretion by SMCs amongst other cells, ECM remodelling due to the matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) produced by SMCs amongst other cells. A set of complementary reaction–diffusion equations for the formation of PDGF, MMP, and TIMP was presented. Values of the parameters used in the simulations were derived from the literature.
In contrast, Cilla et al.19 neglected diffusion and convection terms of the differential equation of SMCs behavior due to their large size and because they do not spread due to diffusion. Model parameters, such as concentration and passing rate into the intima were depicted in the literature along with appropriate boundary conditions.38,107 A similar approach was adopted by Mckay et al.64 and Ibragimov et al.45 Summary of the governing equations used in SMCs proliferation is shown in Table 9.
Collagen Formation
The formation of collagen, the extracellular matrix created by the SMCs, was described in the work of Mckay et al.64 using production and degradation rates. The process of collagen formation was also included in Cilla et al.19 model simplified the biochemical process by neglecting the diffusion and the convection terms, thus leaving only the secretion and the degradation rates using values presented in the literature. Details of the governing equations used in the collagen formation are depicted in Table 10.
Atherosclerotic Plaque Growth and Rupture
Atherosclerotic plaque fate has been extensively studied so far. Atherosclerosis growth could be categorised based on whether they use ODEs or PDEs with the vast majority of the models incorporating PDEs whereas only a small fraction entails ODEs.11,20,21,45,71,108,111 Following, a comprehensive analysis of plaque growth models and their simplifications, modelling is presented categorised as 2D and 3D.
Two-dimensional models, tabulated in Table 11, are the majority of the published work so far addressing progress and growth of the atherosclerotic plaque. What is common among all existing studies is the great number of simplifications applied to these models. Nevertheless, some striking features are noticed concerning the methodology followed by the authors. As such, one of the first studies correlated arterial plaque growth with a growth rate constant derived from empirical data, material properties, and the monocytes accumulation in the arterial wall.112 The study also proposed that the fibrous cap rupture could be described in terms of stored energy occurring at a critical time that depends on the value of the hydrostatic pressure; when the pressure exceeds a threshold, rupture occurs. Another approach was presented by Li et al.58 suggesting that Arbitrary Lagrangian–Eulerian (ALE) and Ogden strain energy methodologies could describe the fluid flow and plaque structure interplay. Some of the simplifications of this work are the use of concentric plaque geometry, the lack of morphological accurate factors such as the lipid core due to macrophages, and finally the vessel geometry. Fazli et al.29 indicated that the growth rate of the plaque is not linear with time and the rate is high in the beginning, then it becomes smaller and finally it increases again but not as much as the growth rate in the beginning. A few years later, a modified version of the model by Zohdi et al.112 including macrophages, ox-LDL, monocytes and foam cells was published by Bulelzai and Dubbeldam.11 disregarding the role of SMCs and collagen in the plaque formation and growth. A completely different approach was presented by Fok33; a single ordinary differential equation free of boundary conditions to describe the evolution of arterial stenosis driven by the SMCs flux from the media, their proliferation, and subsequent death. Other recent studies proposed a 1D model of lesion growth assuming ECM, smooth cells and other biological factors do not participate in the inflammatory process and a temporal scale-independent model without mass conservation in the lesion and only LDL mass transport considered.35,89 One of the more comprehensive models was proposed by Hao and Friedman42 where the plaque weight estimation includes the macrophages, the T-cells, the foam cells, the SMCs, and the ECM density. Finally, one of the latest works employed the ALE method to solve the equations in both the fluid and the solid domain one of the key features of the results was the observation of a two-humps plaque shape instead of a bell-shaped one.106 Despite the capability to simulate the plaque growth, several biochemical factors were disregarded, and the vessel wall density was assumed to be a constant value, independent of time.
On the other hand, 3D models are scarce. The governing equations used in the 3D atherosclerotic plaque growth models are tabulated in Table 12. One of the first attempts proposed a 3D model with a plaque growth function calculating the increase of the wall thickness.61 The linear function implemented two constants representing the relation between coronary artery diameter change and wall shear stress in a 3-year period, and the time-averaged wall shear stress. In general, this model has limited applicability since it could only serve for simulating the plaque initiation. Filipovic et al.32 correlated intimal thickening to the shear stress via a system of PDEs simulating the inflammatory process. In order to follow the change of the vessel wall geometry during plaque growth, a 3D mesh moving algorithm was applied. They also simplified the inflammatory process disregarding smooth muscle cell proliferation and foam cells formation including only ox-LDL, macrophages, and cytokines. Another approach correlates growth of the plaque to the accumulation of foam cells, SMCs, and collagen.19 The velocity of the growth was related to the variation of SMCs, the volume of the spherical foam cells and the ellipsoidal SMCs. Finally, one of the latest multiscale models utilises the occupied volume due to the foam cells stratification, the volume of the accumulated foam cells, and the portion of endothelium in the fatty streak formation.99,100 A threshold of 1% was set as the maximum arterial wall deformation without significant impact on the blood flow dynamics.
The validation of the aforementioned models is also important and the relevant information in the corresponding studies is shown in Table 13.
Perspectives and Challenges
All the aforementioned mathematical models incorporate simplifications regarding the biochemical processes involved in the lesion formation and the atheromatous plaque progress. Nevertheless, the computational procedure is based on several parameters regarding cell dynamics, such as diffusion and concentration. Despite the fact that additional experiments are needed so as to fine tune several of these parameters, it should be also noted that these parameters cover only a fraction of the biochemical processes involved in the development of the lesion. The interplay of other factors such as triglycerides, HDL, B cells, sterol regulatory elements, signaling proteins has not yet been sufficiently described by mathematical equations or computational models. Even though a significant amount of work is published so far regarding the build-up of the plaque, this could only be considered as the tip of the iceberg. Consequences of the progression of the atheromatous plaque such as plaque rupture due to its vulnerability to the subjected stresses and subsequent thrombus formation are still unexplored since only few studies are published presenting concise results. In view of this, the purpose of the scientific community to suggest a reliable tool to predict areas of the vasculature prone to developing atheromatous plaque and, at the same time, predict the risk of huge plaque rupture posing life-threatening consequences to the patient, remains largely unfulfilled.
Despite the huge efforts that have been made so far, a lot of uncertainties exist and should be convincingly clarified before pursuing a more complete multiscale computational platform. Next, we attempt to briefly point out some of these uncertainties in the present state of the art.
First, the nature of the blood and the subsequent modelling method is very important. Part of the published studies model blood as a Newtonian fluid, whereas others prefer non-Newtonian approach. Recent studies comparing available blood rheological models demonstrated some of the misconceptions when performing cardiovascular simulations. Skiadopoulos et al.91 concluded that WSS distribution pattern is unconstrained by the rheological model contrarily to its magnitude and oscillations, which is in accordance with Ai and Vafai.2 In their work, it was found that Newtonian model performs satisfactorily in high shear and flow rates, but the formation of atheromatous lesions is overestimated in areas where WSS exhibits an oscillating nature. Another aspect related to the blood flow nature is the development of the recirculation zone and the impact on WSS distribution in cases of large stenosis. It was shown by Nematollahi et al.67 that the recirculation zone in arteries with severe stenosis, and the decrease of WSS in the reattachment points, which favors disease progress, is inadequately modeled with a Newtonian approximation. Similar findings were presented by Millon et al.,65 stressing the existence of atherosclerotic lesions in the segment after the stenosis and not before, which was correlated with the low WSS distribution in the post-stenosis area. It has been also stressed that the recirculation zones generated by the plaque development and the ongoing change of the blood flow profile are related to phenomena that are indicative of possible plaque rupture. Such phenomena are delamination and erosion, yet there is no solid evidence for their dependency on WSS distribution.7 Nevertheless, Non-Newtonian constitutive equations for blood tend to Newtonian behavior at high shear rates and therefore their use makes sense for shear rates typically lower than 50 s−1, at which the residence time of red blood cells—a key aspect of Non-Newtonian behavior—should be taken into account.5
Secondly, the introduction of more realistic geometries would greatly favor blood flow assessment, the interconnected onset of the inflammatory process, and the disease progress. Up-to-date techniques enable the reconstruction of patient-specific geometries facilitating the observation of the cardiovascular disease in several conditions: disease-free and through several stages of the inflammatory process and subsequent plaque growth. The continuous progress in computed tomography coronary angiography is sought to elucidate the onset and progress of the disease with respect to interpatient and intrapatient variability. Differentiations of carotid, femoral, and coronary arteries amongst different patients will enhance prognosis of the prone regions due to different shear stress distribution, as well as the in-time evaluation of the plaque rupture risk. In addition, anatomical variations of the same type of artery in a group of patients would lead to more sophisticated model predictions since each vasculature region would respond differently in the blood flow dynamics.14,55 This approach necessitates more accurate and patient-oriented boundary conditions of the blood flow and the mass transport since each patient profile varies because of the age, the lifestyle, or other underlying diseases.24,81
Thirdly, biological tissue’s transport properties pose an additional challenge. To date, the multi-layer approach is the most common methodology to describe the arterial wall. The set of equations and the corresponding boundary conditions provide a realistic description of the biological tissue anatomy. Nonetheless, development of more sophisticated predictive tools is dependent to more accurate parameters involved in the biological transport phenomena, such as the permeability, the porosity, and the diffusivity. Likewise, other important factors are the upscale of animal experimental results to humans, the lack of human-tissue properties and the lack of information regarding the transition phase between normal and stenosed arteries.50 Further advances in multiscale modelling tools depend on data regarding cell -population dynamics, lipid-core formation, and fibrous cap as well as plaque rupture.106 In this context, a suggested option is to modify the four-layer model to account for the glycocalyx effect or the artery wall layers thickness variability thus yielding a more sophisticated model for the plaque morphology in the circumferential and vertical direction.49,106
Finally, a significant goal is the establishment of an equilibrium state via modifying either the macrophage or the HDL influx or reduce LDL levels by using statins. Early findings suggest that plaque regression could be facilitated,8,9 and an equilibrium could be achieved if the macrophage influx is modified at its early stage. Identification of such a time window is crucial since macrophage influx reduction in a later stage of the atheromatous progression would only result in a slower growth rate.21,22,57,66 Another aspect of the atherosclerosis disease study with increasing interest is the plaque growth regression due to HDL particles mimicking high lipid proteins.4,86,97,110 Purpose of these studies was to examine the ability to achieve plaque equilibrium at its early stage when its size is relatively small. On the other hand, results have shown that efforts to engineer the fate of a larger plaque are less effective. Modelling studies incorporating HDL effect are scarce to date.21,34 Recently, Friedman and Hao34 predicted plaque weight and macrophage density decline because of increase in HDL efficiency, however, no equilibrium was reached. Authors noted that the plaque regression observed in clinical studies with animals is not observed in human clinical studies with a late-stage plaque of complicated structure. Future work should address the efficacy of HDL increase towards achieving plaque equilibrium in patients with early-stage plaque, adding more clinical evidence regarding patients with late-stage atheromatous plaque and already suffering from subsequent symptoms.
Conclusions
Despite the great effort been made so far, it is not yet possible to comprehensively predict or re-engineer the fate of atherosclerosis. Close cooperation by experts from different sectors such as medicine, engineering, physics, and chemistry in this multidisciplinary problem would seek more experimental research generating customised data for necessary parameters involved in particles transport inside the arterial wall. Consequently, modeling accuracy could be upgraded regarding arterial properties, blood flow dynamics, biochemical processes, and boundary conditions. This would be a crucial step towards in silico biomedical trials that are expected to have a deep impact to the patient quality of life, the medical procedures and the economics of cardiovascular diseases.
References
Achenbach, S. Quantification of coronary artery stenoses by computed tomography. JACC Cardiovasc. Imaging 1:472–474, 2008.
Ai, L., and K. Vafai. An investigation of stokes’ second problem for non-Newtonian fluids. Numer. Heat Transf. Part A Appl. 47:955–980, 2005.
Ai, L., and K. Vafai. A coupling model for macromolecule transport in a stenosed arterial wall. Int. J. Heat Mass Transf. 49:1568–1591, 2006.
Andrews, J., A. Janssan, T. Nguyen, A. D. Pisaniello, D. J. Scherer, J. J. P. Kastelein, B. Merkely, S. E. Nissen, K. Ray, G. G. Schwartz, S. G. Worthley, C. Keyserling, J.-L. Dasseux, J. Butters, J. Girardi, R. Miller, and S. J. Nicholls. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. Cardiovasc. Diagn. Ther. 7:45–51, 2017.
Arzani, A. Accounting for residence-time in blood rheology models: do we really need non-Newtonian blood flow modelling in large arteries? J. R. Soc. Interface 15:146, 2018.
Arzani, A., A. M. Gambaruto, G. Chen, and S. C. Shadden. Wall shear stress exposure time: a Lagrangian measure of near-wall stagnation and concentration in cardiovascular flows. Biomech. Model. Mechanobiol. 16:787–803, 2017.
Assemat, P., K. K. Siu, J. A. Armitage, S. N. Hokke, A. Dart, J. Chin-Dusting, and K. Hourigan. Haemodynamical stress in mouse aortic arch with atherosclerotic plaques: preliminary study of plaque progression. Comput. Struct. Biotechnol. J. 10:98–106, 2014.
Badimon, J. J., L. Badimon, and V. Fuster. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85:1234–1241, 1990.
Belalcazar, L. M., A. Merched, B. Carr, K. Oka, K.-H. Chen, L. Pastore, A. Beaudet, and L. Chan. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 107:2726–2732, 2003.
Bhalla, G., and W. M. Deen. Effects of charge on osmotic reflection coefficients of macromolecules in fibrous membranes. Biophys. J. 97:1595–1605, 2009.
Bulelzai, M. A. K., and J. L. A. Dubbeldam. Long time evolution of atherosclerotic plaques. J. Theor. Biol. 297:1–10, 2012.
Calvez, V., and A. Ebde. Mathematical modelling of the atherosclerotic plaque formation. ESAIM Proc. CEMRACS 2008 - Model. Numer. Simul. Complex Fluids 1–16, 2010. https://doi.org/10.1051/proc/2009036
Chalmers, A. D., C. A. Bursill, and M. R. Myerscough. Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression. PLoS ONE 12:1–23, 2017.
Chatzizisis, Y. S., A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling.molecular, cellular, and vascular behavior. J. Am. Coll. Cardiol. 49:2379–2393, 2007.
Chen, D., J. M. Roda, C. B. Marsh, T. D. Eubank, and A. Friedman. Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model. Bull. Math. Biol. 74:2752–2777, 2012.
Cheng, C., D. Tempel, R. Van Haperen, A. Van Der Baan, F. Grosveld, M. J. A. P. Daemen, R. Krams, and R. De Crom. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 113:2744–2753, 2006.
Cheng, X., and P. M. Pinsky. The balance of fluid and osmotic pressures across active biological membranes with application to the corneal endothelium. PLoS ONE 10:1–18, 2015.
Chien, S. Molecular and mechanical bases of focal lipid accumulation in arterial wall. Prog. Biophys. Mol. Biol. 83:131–151, 2003.
Cilla, M., E. Pena, and M. A. Martinez. Mathematical modelling of atheroma plaque formation and development in coronary arteries. J. R. Soc. Interface 11:20130866, 2013.
Cobbold, C. A., J. A. Sherratt, and S. R. J. Maxwell. Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach. Bull. Math. Biol. 64:65–95, 2002.
Cohen, A., M. R. Myerscough, and R. S. Thompson. Athero-protective effects of high density lipoproteins (HDL): an ODE model of the early stages of atherosclerosis. Bull. Math. Biol. 76:1117–1142, 2014.
Craeyveld, E., S. C. Gordts, E. Nefyodova, F. Jacobs, and B. De Geest. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies. J. Mol. Med. 89:555–567, 2011.
Cunningham, K. S., and A. I. Gotlieb. The role of shear stress in the pathogenesis of atherosclerosis. Lab. Investig. 85:9–23, 2005.
Dabagh, M., P. Jalali, and J. M. Tarbell. The transport of LDL across the deformable arterial wall: the effect of endothelial cell turnover and intimal deformation under hypertension. Am J Physiol Heart Circ Physiol 297:H983–H996, 2009.
Díaz-Zuccarini, V., O. Agu, G. Di Tomaso, and C. Pichardo-Almarza. Towards personalised management of atherosclerosis via computational models in vascular clinics: technology based on patient-specific simulation approach. Healthcare Technol. Lett. 1:13–18, 2014.
Farghadan, A., and A. Arzani. The combined effect of wall shear stress topology and magnitude on cardiovascular mass transport. Int. J. Heat Mass Transf. 131:252–260, 2019.
Farid, A. S., and Y. Horii. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis. Lipids Health Dis. 11:1–15, 2012.
Fatouraee, N., X. Deng, A. De Champlain, and R. Guidoin. Concentration polarization of low density lipoproteins (LDL) in the arterial system. Ann. N. Y. Acad. Sci. 858:137–146, 1998.
Fazli, S., E. Shirani, and M. R. Sadeghi. Numerical simulation of LDL mass transfer in a common carotid artery under pulsatile flows. J. Biomech. 44:68–76, 2011.
Feig, J. E., J. X. Rong, R. Shamir, M. Sanson, Y. Vengrenyuk, J. Liu, K. Rayner, K. Moore, M. Garabedian, and E. A. Fisher. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl. Acad. Sci. 108:7166–7171, 2011.
Filipovic, N., D. Fotiadis, W. Pelosi, and O. Parodi. Experimental and computer model of plaque formation in the artery. 10th Int. Work. Biomed. Eng. BioEng 2011 1–4, 2011. https://doi.org/10.1109/iwbe.2011.6079029
Filipovic, N., Z. Teng, M. Radovic, I. Saveljic, D. Fotiadis, and O. Parodi. Computer simulation of three-dimensional plaque formation and progression in the carotid artery. Med. Biol. Eng. Comput. 51:607–616, 2013.
Fok, P. W. Mathematical model of intimal thickening in atherosclerosis: vessel stenosis as a free boundary problem. J. Theor. Biol. 314:23–33, 2012.
Friedman, A., and W. Hao. A mathematical model of atherosclerosis with reverse cholesterol transport and associated risk factors. Bull. Math. Biol. 77:758–781, 2015.
Gabriel, S. A., Y. Ding, Y. Feng, and J. A. Gear. Deposition-driven growth in atherosclerosis modelling. 19th Australas. Fluid Mech. Conf. 1–5, 2014.
Gessaghi, V. C., M. A. Raschi, D. Y. Tanoni, C. A. Perazzo, and A. E. Larreteguy. Growth model for cholesterol accumulation in the wall of a simplified 3D geometry of the carotid bifurcation. Comput. Methods Appl. Mech. Eng. 200:2117–2125, 2011.
Gistera, A., and G. K. Hansson. The immunology of atherosclerosis. Nat. Rev. Nephrol. 13:368–380, 2017.
Griffin, C. A., L. H. Apponi, K. K. Long, and G. K. Pavlath. Chemokine expression and control of muscle cell migration during myogenesis. J. Cell Sci. 123:3052–3060, 2010.
Guyton, J. R., and K. F. Klemp. Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am. J. Pathol. 143:1444–1457, 1993.
Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685–1695, 2005.
Hansson, G. K., A.-K. L. Robertson, and C. Söderberg-Nauclér. Inflammation and atherosclerosis. Annu. Rev. Pathol. Mech. Dis. 1:297–329, 2006.
Hao, W., and A. Friedman. The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model. PLoS ONE 9:1–15, 2014.
Hodson, S., and R. Earlam. The incorporation of gel pressure into the irreversible thermodynamic equation of fluid flow in order to explain biological tissue swelling. J. Theor. Biol. 163:173–180, 1993.
Homma, S., N. Hirose, H. Ishida, T. Ishii, G. Araki, and J. H. Halsey. Carotid plaque and intima-media thickness assessed by B-mode ultrasonography in subjects ranging from young adults to centenarians editorial comment. Stroke 32:830–835, 2001.
Ibragimov, A. I., C. J. McNeal, L. R. Ritter, and J. R. Walton. A mathematical model of atherogenesis as an inflammatory response. Math. Med. Biol. 22:305–333, 2005.
Karner, G., and K. Perktold. Effect of endothelial injury and increased blood pressure on albumin accumulation in the arterial wall: a numerical study. J. Biomech. 33:709–715, 2000.
Kedem, O. A physical interpretation of the phenomenological coefficients of membrane permeability. J. Gen. Physiol. 45:143–179, 1961.
Kedem, O., and A. Katchalsky. Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. Biochim. Biophys. Acta 27:229–246, 1958.
Kenjeres, S., and A. de Loor. Modelling and simulation of low-density lipoprotein transport through multi-layered wall of an anatomically realistic carotid artery bifurcation. J. R. Soc. Interface 11:20130941, 2013.
Khakpour, M., and K. Vafai. Critical assessment of arterial transport models. Int. J. Heat Mass Transf. 51:807–822, 2008.
Khaled, A.-R. A., and K. Vafai. The role of porous media in modeling flow and heat transfer in biological tissues. Int. J. Heat Mass Transf. 46:4989–5003, 2003.
El Khatib, N., S. Génieys, B. Kazmierczak, and V. Volpert. Mathematical modelling of atherosclerosis as an inflammatory disease. Philos. Trans. A. Math. Phys. Eng. Sci. 367:4877–4886, 2009.
El Khatib, N., S. Génieys, and V. Volpert. Atherosclerosis initiation modeled as an inflammatory process. Math. Model. Nat. Phenom. 2:126–141, 2007.
Kolandavel, M. K., E. T. Fruend, S. Ringgaard, and P. G. Walker. The effects of time varying curvature on species transport in coronary arteries. Ann. Biomed. Eng. 34:1820–1832, 2006.
Lee, J. M., G. Choi, D. Hwang, J. Park, H. J. Kim, J. H. Doh, C. W. Nam, S. H. Na, E. S. Shin, C. A. Taylor, and B. K. Koo. Impact of longitudinal lesion geometry on location of plaque rupture and clinical presentations. JACC Cardiovasc. Imaging 10:677–688, 2017.
Li, L.-Y. Transport of multicomponent ionic solutions in membrane systems. Philos. Mag. Lett. 84:593–599, 2004.
Li, R., H. Chao, K. W. S. Ko, S. Cormier, C. Dieker, E. A. Nour, S. Wang, L. Chan, and K. Oka. Gene therapy targeting LDL cholesterol but not HDL cholesterol induces regression of advanced atherosclerosis in a mouse model of familial hypercholesterolemia. J. Genet. Syndr. Gene Ther. 106:1–22, 2012.
Li, Z. Y., S. P. S. Howarth, T. Tang, and J. H. Gillard. How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 37:1195–1199, 2006.
Libby, P., and P. M. Ridker. Inflammation and atherothrombosis. From population biology and bench research to clinical practice. J. Am. Coll. Cardiol. 48:A33, 2006.
Libby, P., P. M. Ridker, and A. Maseri. Inflammation and atherosclerosis. Circulation 105:1135–1143, 2002.
Liu, B., and D. Tang. Computer simulations of atherosclerotic plaque growth in coronary arteries. Mol. Cell Biomech. 7:193–202, 2010.
Lovren, F., Y. Pan, A. Quan, K. K. Singh, P. C. Shukla, N. Gupta, B. M. Steer, A. J. Ingram, M. Gupta, M. Al-Omran, H. Teoh, P. A. Marsden, and S. Verma. MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126:S81, 2012.
Maiolino, G., G. Rossitto, P. Caielli, V. Bisogni, G. P. Rossi, and L. A. Calò. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediat. Inflamm. 2013:714653, 2013.
Mckay, C., S. Mckee, N. Mottram, T. Mulholland, S. Wilson, S. Kennedy, and R. Wadsworth. Towards a model of atherosclerosis, 2004. http://www.mathstat.strath.ac.uk/downloads/publications/2005-4atheroreport-2.pdf
Millon, A., M. Sigovan, L. Boussel, J. L. Mathevet, V. Louzier, C. Paquet, A. Geloen, N. Provost, Z. Majd, D. Patsouris, A. Serusclat, and E. Canet-Soulas. Low WSS induces intimal thickening, while large WSS variation and inflammation induce medial thinning, in an animal model of atherosclerosis. PLoS ONE 10:1–14, 2015.
Morton, J., S. Bao, D. Celermajer, M. Ng, and C. Bursill. Striking differences between the atheroprotective effects of high density lipoproteins in early-stage and late-stage atherosclerosis: insights into the lack of efficacy of HDL-raising therapy. Hear. Lung Circ. 22:S66–S67, 2013.
Nematollahi, A., E. Shirani, I. Mirzaee, and M. R. Sadeghi. Numerical simulation of LDL particles mass transport in human carotid artery under steady state conditions. Sci. Iran. 19:519–524, 2012.
Nematollahi, A., E. Shirani, M. R. Sadeghi, and I. Mirzaee. Effects of shear-dependent transport properties on lumen surface concentration of LDL particles in stenosed carotid artery. Meccanica 50:1733–1746, 2015.
Newby, A. C., and A. B. Zaltsman. Fibrous cap formation or destruction—the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 41:345–360, 1999.
Olgac, U., V. Kurtcuoglu, and D. Poulikakos. Computational modeling of coupled blood-wall mass transport of LDL: effects of local wall shear stress. Am J Physiol Heart Circ Physiol 294:H909–H919, 2008.
Ougrinovskaia, A., R. S. Thompson, and M. R. Myerscough. An ODE model of early stages of atherosclerosis: mechanisms of the inflammatory response. Bull. Math. Biol. 72:1534–1561, 2010.
Panousis, C. G., G. Evans, and S. H. Zuckerman. TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma. J. Lipid Res. 42:856–863, 2001.
Patlak, C. S., D. A. Goldstein, and J. F. Hoffman. The flow of solute and solvent across a two-membrane system. J. Theor. Biol. 5:426–442, 1963.
Prosi, M., P. Zunino, K. Perktold, and A. Quarteroni. Mathematical and numerical models for transfer of low-density lipoproteins through the arterial walls: a new methodology for the model set up with applications to the study of disturbed lumenal flow. J. Biomech. 38:903–917, 2005.
Rappitsch, G., and K. Perktold. Computer simulation of convective diffusion processes in large arteries. J. Biomech. 29:207–215, 1996.
Rappitsch, G., K. Perktold, and E. Pernkopf. Numerical modelling of shear-dependent mass transfer in large arteries. Int. J. Numer. Methods Fluids 25:847–857, 1997.
Rayner, K. J., F. J. Sheedy, C. C. Esau, F. N. Hussain, R. E. Temel, S. Parathath, J. M. Van Gils, A. J. Rayner, A. N. Chang, Y. Suarez, C. Fernandez-Hernando, E. A. Fisher, and K. J. Moore. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121:2921–2931, 2011.
Reddy, S., and P. Seshaiyer. Stability analysis of a model of atherosclerotic plaque growth. Comput. Math. Methods Med. 1–7:2015, 2015.
Rhodes, J., J. Sharkey, and P. Andrews. Serum IL-8 and MCP-1 concentration do not identify patients with enlarging contusions after traumatic brain injury. J. Trauma Inj. Infect. Crit. Care 66:1591–1597, 2009.
Rohatgi, A., A. Khera, J. D. Berry, E. G. Givens, C. R. Ayers, K. E. Wedin, I. J. Neeland, I. S. Yuhanna, D. R. Rader, J. A. de Lemos, and P. W. Shaul. HDL cholesterol efflux capacity and incident cardiovascular events. N. Engl. J. Med. 371:2383–2393, 2014.
Sakellarios, A. I., M. I. Papafaklis, P. Siogkas, L. S. Athanasiou, T. P. Exarchos, K. Stefanou, C. V. Bourantas, K. K. Naka, L. K. Michalis, O. Parodi, and D. I. Fotiadis. Patient-specific computational modeling of subendothelial LDL accumulation in a stenosed right coronary artery: effect of hemodynamic and biological factors. AJP Heart Circ. Physiol. 304:H1455–H1470, 2013.
Schiopu, A., B. Frendéus, B. Jansson, I. Söderberg, I. Ljungcrantz, Z. Araya, P. K. Shah, R. Carlsson, J. Nilsson, and G. N. Fredrikson. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid Regression of atherosclerosis in Apobec-1-/-/low-density lipoprotein receptor-/- mice. J. Am. Coll. Cardiol. 50:2313–2318, 2007.
Schwenke, D., and T. Carew. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. Atherosclerosis 9:908–919, 1989.
Seneviratne, A. N., B. Sivagurunathan, and C. Monaco. Toll-like receptors and macrophage activation in atherosclerosis. Clin. Chim. Acta 413:3–14, 2012.
Shaaban, A., and A. Duerinckx. Wall shear stress and early atherosclerosis: a review. AJR Am. J. Roentgenol. 174:1657–1665, 2000.
Shaw, J. A., A. Bobik, A. Murphy, P. Kanellakis, P. Blombery, N. Mukhamedova, K. Woollard, S. Lyon, D. Sviridov, and A. M. Dart. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ. Res. 103:1084–1091, 2008.
Shu, L., X. Liu, Y. Li, B. Yang, S. Huang, Y. Lin, and S. Jin. Modified Kedem-Katchalsky equations for osmosis through nano-pore. Desalination 399:47–52, 2016.
Silence, J., D. Collen, and H. R. Lijnen. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ. Res. 90:897–903, 2002.
Silva, T., A. Sequeira, R. Santos, and J. Tiago. Mathematical modeling of atherosclerotic plaque formation coupled with a non-Newtonian model of blood flow. Conf. Pap. Math. 1–14:2013, 2013.
Siogkas, P., A. Sakellarios, T. P. Exarchos, L. Athanasiou, E. Karvounis, K. Stefanou, E. Fotiou, D. I. Fotiadis, K. K. Naka, L. K. Michalis, N. Filipovic, and O. Parodi. Multiscale—patient-specific artery and atherogenesis models. IEEE Trans. Biomed. Eng. 58:3464–3468, 2011.
Skiadopoulos, A., P. Neofytou, and C. Housiadas. Comparison of blood rheological models in patient specific cardiovascular system simulations. J. Hydrodyn. 29:293–304, 2017.
Stadius, M. L., R. Rowan, J. F. Fleischhauer, R. Kernoff, M. Billingham, and A. M. Gown. Time course and cellular characteristics of the iliac artery response to acute balloon injury: an angiographic, morphometric, and immunocytochemical analysis in the cholesterol-fed New Zealand white rabbit. Arterioscler. Thromb. Vasc. Biol. 12:1267–1273, 1992.
Stanbro, W. D. Modeling the interaction of peroxynitrite with low-density lipoproteins. II: reaction/diffusion model of peroxynitrite in low-density lipoprotein particles. J. Theor. Biol. 205:465–471, 2000.
Stangeby, D. K., and C. R. Ethier. Coupled computational analysis of arterial LDLtransport—effects of hypertension. Comput. Methods Biomech. Biomed. Engin. 5:233–241, 2002.
Stone, P. H., C. M. Gibson, R. C. Pasternak, K. Mcmanus, L. Diaz, T. Boucher, R. Spears, T. Sandor, B. Rosner, and F. M. Sacks. Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trial of coronary regression. Am. J. Cardiol. 71:766–772, 1993.
Sun, N., N. B. Wood, A. D. Hughes, S. A. M. Thom, and X. Y. Xu. Fluid-wall modelling of mass transfer in an axisymmetric Stenosis: effects of shear-dependent transport properties. Ann. Biomed. Eng. 34:1119–1128, 2006.
Tardy, C., M. Goffinet, N. Boubekeur, R. Ackermann, G. Sy, A. Bluteau, G. Cholez, C. Keyserling, N. Lalwani, J. F. Paolini, J. L. Dasseux, R. Barbaras, and R. Baron. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis 232:110–118, 2014.
Tedgui, A., and M. J. Lever. Filtration through damaged and undamaged rabbit thoracic aorta. Am. J. Physiol. 247:H784–H791, 1984.
Tomaso, G., V. Daz-Zuccarini, and C. Pichardo-Almarza. A multiscale model of atherosclerotic plaque formation at its early stage. IEEE Trans. Biomed. Eng. 58:3460–3463, 2011.
Tomaso, G., C. Pichardo-Almarza, O. Agu, and V. Díaz-Zuccarini. A multiscale and patient-specific computational framework of atherosclerosis formation and progression: a case study in the aorta and peripheral arteries. Proc. Comput. Sci. 51:1118–1127, 2015.
Vafai, K., and C. L. Tien. Boundary and inertia effects on flow and heat transfer in porous media. Int. J. Heat Mass Transf. 24:195–203, 1981.
Wang, S., and K. Vafai. Analysis of low density lipoprotein (LDL) transport within a curved artery. Ann. Biomed. Eng. 43:1571–1584, 2015.
Wu, M.-Y., C.-J. Li, M.-F. Hou, and P.-Y. Chu. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 18:2034, 2017.
Yang, N., and K. Vafai. Modeling of low-density lipoprotein (LDL) transport in the artery-effects of hypertension. Int. J. Heat Mass Transf. 49:850–867, 2006.
Yang, N., and K. Vafai. Low-density lipoprotein (LDL) transport in an artery—a simplified analytical solution. Int. J. Heat Mass Transf. 51:497–505, 2008.
Yang, Y., W. Jäger, M. Neuss-Radu, and T. Richter. Mathematical modeling and simulation of the evolution of plaques in blood vessels. J. Math. Biol. 72:973–996, 2016.
Zahedmanesh, H., H. Van Oosterwyck, and C. Lally. A multi-scale mechanobiological model of in-stent restenosis: deciphering the role of matrix metalloproteinase and extracellular matrix changes. Comput. Methods Biomech. Biomed. Engin. 17:813–828, 2014.
Zhang, S., L. R. Ritter, and A. I. Ibragimov. Foam cell formation in atherosclerosis: HDL and macrophage reverse cholesterol transport. Discret. Contin. Dyn. Syst. Ser. 2013. https://doi.org/10.3934/proc.2013.2013.825.
Zhao, W., C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175:2635–2642, 2005.
Zheng, K. H., F. M. van der Valk, L. P. Smits, M. Sandberg, J. L. Dasseux, R. Baron, R. Barbaras, C. Keyserling, B. F. Coolen, A. J. Nederveen, H. J. Verberne, T. E. Nell, D. J. Vugts, R. Duivenvoorden, Z. A. Fayad, W. J. M. Mulder, G. A. M. S. van Dongen, and E. S. G. Stroes. HDL mimetic CER-001 targets atherosclerotic plaques in patients. Atherosclerosis 251:381–388, 2016.
Zohdi, T. I. A simple model for shear stress mediated lumen reduction in blood vessels. Biomech. Model. Mechanobiol. 4:57–61, 2005.
Zohdi, T. I., G. A. Holzapfel, and S. A. Berger. A phenomenological model for atherosclerotic plaque growth and rupture. J. Theor. Biol. 227:437–443, 2004.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Dan Elson oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Avgerinos, N.A., Neofytou, P. Mathematical Modelling and Simulation of Atherosclerosis Formation and Progress: A Review. Ann Biomed Eng 47, 1764–1785 (2019). https://doi.org/10.1007/s10439-019-02268-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-019-02268-3